Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: A report on 62 cases

Leukemia Research

Volumn 35, Issue 7, 2011, Pages 863-867

  Braun, Thorsten ^a   de Botton, Stéphane ^b,f   Taksin, Anne Laure ^c   Park, Sophie ^d   Beyne Rauzy, Odile ^e   Coiteux, Valérie ^f   Sapena, Rosa ^d   Lazareth, Anne ^a   Leroux, Geneviève ^a   Guenda, Khaled ^a   Cassinat, Bruno ^g   Fontenay, Michaela ^d   Vey, Norbert ^h   Guerci, Agnès ⁱ   Dreyfus, François ^d   Bordessoule, Dominique ^j   Stamatoullas, Aspasia ^k   Castaigne, Sylvie ^c   Terré, Christine ^c   Eclache, Virginie ^a   Fenaux, Pierre ^a   Adès, Lionel ^a   more..

^a AVICENNE HOSPITAL   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c CENTRE HOSPITALIER DE VERSAILLES   (France)

^d Service des Maladies du Sang ^*  (France)

^e CHU PURPAN   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g SAINT LOUIS HOSPITAL   (France)

^h INSTITUT PAOLI CALMETTES   (France)

ⁱ UNIVERSITY HOSPITAL OF NANCY   (France)

^j DUPUYTREN UNIVERSITY HOSPITAL   (France)

^k ROUEN UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Del 20q; Immunologic thrombocytopenic purpura; Myelodysplastic syndromes; Thrombocytopenia; WHO classification

Indexed keywords

HEMOGLOBIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BLAST CELL; BONE MARROW BIOPSY; CANCER SURVIVAL; CELL COUNT; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME DELETION 20Q; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY ANEMIA; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA AND RINGED SIDEROBLASTS; RETICULOCYTE COUNT; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 20; FEMALE; HUMANS; KARYOTYPING; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; SURVIVAL RATE;

EID: 79958726106     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.02.008     Document Type: Article

References (20)

1. Fenaux P. Myelodysplastic syndromes: from pathogenesis and prognosis to treatment. Semin Hematol 2004, 41:6-12.
2. Bench A.J., Nacheva E.P., Hood T.L., Holden J.L., French L., Swanton S., et al. Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. UK Cancer Cytogenetics Group (UKCCG). Oncogene 2000, 19:3902-3913.
3. Haase D., Germing U., Schanz J., Pfeilstöcker M., Nösslinger T., Hildebrandt B., et al. New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. Blood 2007, 110:4385-4395.
4. Hofmann W.K., Lubbert M., Hoelzer D., Koeffler H.P. Myelodysplastic syndromes. Hematol J 2004, 5:1-8.
5. Huh J., Tiu R.V., Gondek L.P., O'Keefe C.L., Jasek M., Makishima H., et al. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis. Genes Chromosomes Cancer 2010, 49:390-399.
6. Greenberg P., Cox C., LeBeau M.M., Fenaux P., Morel P., Sanz G., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997, 89:2079-2088.
7. Gupta R., Soupir C.P., Johari V., Hasserjian R.P. Myelodysplastic syndrome with isolated deletion of chromosome 20q: an indolent disease with minimal morphological dysplasia and frequent thrombocytopenic presentation. Br J Haematol 2007, 139:265-268.
8. Soupir C.P., Vergilio J.A., Kelly E., Dal Cin P., Kuter D., Hasserjian R.P. Identification of del(20q) in a subset of patients diagnosed with idiopathic thrombocytopenic purpura. Br J Haematol 2009, 144:800-802.
9. Vardiman J.W., Harris N.L., Brunning R.D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002, 100:2292-2302.
10. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982, 51:189-199.
11. Brunning R.D., Bennett J.M., Flandrin G., Matutes E., Head D., Vardiman J.W., et al. World Health Organization Classification of Tumors. Pathology and genetics of tumours of haematopoietic and lymphoid tissues 2001, IARC Press, Lyon, p. 61-73.
12. Boultwood J., Lewis S., Wainscoat J.S. The 5q-syndrome. Blood 1994, 84:3253-3260.
13. Vardiman J.W., Thiele J., Arber D.A., Brunning R.D., Borowitz M.J., Porwit A., et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009, 114:937-951.
14. Alanio-Brechot C., Schischmanoff P.O., Fénéant-Thibault M., Cynober T., Tchernia G., Delaunay J., et al. Association between myeloid malignancies and acquired deficit in protein 4.1R: a retrospective analysis of six patients. Am J Hematol 2008, 83:275-278.
15. Giagounidis A.A., Germing U., Haase S., Hildebrandt B., Schlegelberger B., Schoch C., et al. Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31. Leukemia 2004, 18:113-119.
16. Hebbar M., Kaplan C., Caulier M.T., Wattel E., Morel P., Wetterwald M., et al. Low incidence of specific anti-platelet antibodies detected by the MAIPA assay in the serum of thrombocytopenic MDS patients and lack of correlation between platelet autoantibodies, platelet lifespan and response to danazol therapy. Br J Haematol 1996, 94:112-115.
17. Bourgeois E., Caulier M.T., Rose C., Dupriez B., Bauters F., Fenaux P. Role of splenectomy in the treatment of myelodysplastic syndromes with peripheral thrombocytopenia: a report on six cases. Leukemia 2001, 15:950-953.
18. Menke D.M., Colon-Otero G., Cockerill K.J., Jenkins R.B., Noel P., Pierre R.V. Refractory thrombocytopenia. A myelodysplastic syndrome that may mimic immune thrombocytopenic purpura. Am J Clin Pathol 1992, 98:502-510.
19. Sashida G., Takaku T.I., Shoji N., Nishimaki J., Ito Y., Miyazawa K., et al. Clinico-hematologic features of myelodysplastic syndrome presenting as isolated thrombocytopenia: an entity with a relatively favorable prognosis. Leuk Lymphoma 2003, 44:653-658.
20. Provan D., Stasi R., Newland A.C., Blanchette V.S., Bolton-Maggs P., Bussel J.B., et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010, 115:168-186.